Avigen, Inc. is a development stage biopharmaceutical company focused on smart drug development and value-creating partnerships.
NEWS
-
Press Release, June 25, 2009
MediciNova and Avigen Confirm Understanding for Key Terms for a Business Combination -
Press Release, May 20, 2009
Avigen Granted AV411 Patent for Neuropathic Pain
- © 2009 Avigen Inc.
- Contact Us
- Home
- Legal Information
- Press Releases
